4 European Projects Found
Searched on 125080 European Projects
FINISHED
REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy (RESPINE)
Start date: Jan 1, 2017, End date: Dec 31, 2020,
The World Health Organisation (WHO) has included low back pain in its list of twelve priority diseases. Notably, Degenerative disc disease (DDD) presents a large, unmet medical need which results in a disabling loss of mechanical function. Today, no efficient therapy is available. Chronic cases often receive surgery, which may lead to biomechanical problems and accelerated degeneration of adjacent ...
Read Project
18
Partners Participants
FINISHED
Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) (STEMBANCC)
Start date: Oct 1, 2012, End date: Sep 30, 2017,
StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug discovery pipeline based upon human induced pluripotent stem cells (hiPSC). This unrivalled opportunity will address the pressing therapeutic need in neurodegeneration, neurodysfunction and diabetes. We have immediate access to richly phenotyped subjects with a we ...
Read Project
38
Partners Participants
FINISHED
A Unique Pancreatic Human Beta Cells to revolutionize the Diabetes Drug Discovery (BETASCREEN)
Start date: Aug 1, 2016, End date: Jan 31, 2017,
Univercell Biosolutions (UB) is a pioneering biotech company providing unique human cell models to accelerate and secure pharmaceutical products. UB is generating 1 M€ turnover in 2015 selling its first generation of human beta cell lines to 10 world pharma industry leaders.Pharmas rentability is decreasing facing to high regulatory pressure and low clinical predictability on human. The rate of cl ...
Read Project
1
Partner Participant
FINISHED
A bioartificial pancreas to treat type 1 diabetes: optimization of cell survival and function in preclinical and clinical phases (BIOSID)
Start date: Jan 1, 2013, End date: Dec 31, 2016,
MAILPAN (MAcroencapsulation of PANcreatic Islets) is a prototype of bioartificial pancreas usable in the human designed to treat type 1 diabetic patients. The prototype was developed along different stages since 1996 and led to the creation of the SME called Defymed in 2011. Next step is now to bring the prototype to the pre-clinical and clinical phases necessary to the ensuing commercialization o ...
Read Project
